These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31356363)

  • 1. Cannabis-based medicines for chronic pain management: current and future prospects.
    Sharon H; Brill S
    Curr Opin Anaesthesiol; 2019 Oct; 32(5):623-628. PubMed ID: 31356363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
    Häuser W; Petzke F; Fitzcharles MA
    Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Aviram J; Samuelly-Leichtag G
    Pain Physician; 2017 Sep; 20(6):E755-E796. PubMed ID: 28934780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cannabis for chronic neuropathic pain.].
    Cuestas E
    Rev Fac Cien Med Univ Nac Cordoba; 2019 Mar; 76(1):1-2. PubMed ID: 30882335
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical Cannabis for Neuropathic Pain.
    Lee G; Grovey B; Furnish T; Wallace M
    Curr Pain Headache Rep; 2018 Feb; 22(1):8. PubMed ID: 29388063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Medical Cannabis in Neuropathic Chronic Pain Management.
    Bennici A; Mannucci C; Calapai F; Cardia L; Ammendolia I; Gangemi S; Calapai G; Griscti Soler D
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cannabinoids for neuropathic pain management].
    Andersen LØ; Enggaard TP; Højsted J
    Ugeskr Laeger; 2018 Feb; 180(9):. PubMed ID: 29506645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and cannabinoids in cancer pain management.
    Meng H; Dai T; Hanlon JG; Downar J; Alibhai SMH; Clarke H
    Curr Opin Support Palliat Care; 2020 Jun; 14(2):87-93. PubMed ID: 32332209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.
    Eisenberg E; Ogintz M; Almog S
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):216-25. PubMed ID: 25118789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management.
    Häuser W; Finn DP; Kalso E; Krcevski-Skvarc N; Kress HG; Morlion B; Perrot S; Schäfer M; Wells C; Brill S
    Eur J Pain; 2018 Oct; 22(9):1547-1564. PubMed ID: 30074291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis for Symptom Management in Older Adults.
    Levy C; Galenbeck E; Magid K
    Med Clin North Am; 2020 May; 104(3):471-489. PubMed ID: 32312410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence.
    Boyaji S; Merkow J; Elman RNM; Kaye AD; Yong RJ; Urman RD
    Curr Pain Headache Rep; 2020 Jan; 24(2):4. PubMed ID: 31980957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis and Cannabinoids for Chronic Pain.
    Romero-Sandoval EA; Kolano AL; Alvarado-Vázquez PA
    Curr Rheumatol Rep; 2017 Oct; 19(11):67. PubMed ID: 28983880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline.
    Busse JW; Vankrunkelsven P; Zeng L; Heen AF; Merglen A; Campbell F; Granan LP; Aertgeerts B; Buchbinder R; Coen M; Juurlink D; Samer C; Siemieniuk RAC; Kumar N; Cooper L; Brown J; Lytvyn L; Zeraatkar D; Wang L; Guyatt GH; Vandvik PO; Agoritsas T
    BMJ; 2021 Sep; 374():n2040. PubMed ID: 34497062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS).
    Ware MA; Wang T; Shapiro S; Collet JP;
    J Pain; 2015 Dec; 16(12):1233-1242. PubMed ID: 26385201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis for Chronic Pain: Challenges and Considerations.
    Romero-Sandoval EA; Fincham JE; Kolano AL; Sharpe BN; Alvarado-Vázquez PA
    Pharmacotherapy; 2018 Jun; 38(6):651-662. PubMed ID: 29637590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry.
    Kawka M; Erridge S; Holvey C; Coomber R; Usmani A; Sajad M; Platt MW; Rucker JJ; Sodergren MH
    J Clin Pharmacol; 2021 Dec; 61(12):1545-1554. PubMed ID: 34473850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain.
    Campbell G; Stockings E; Nielsen S
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):135-144. PubMed ID: 30635715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.